{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T13:29:07Z","timestamp":1778678947472,"version":"3.51.4"},"reference-count":25,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.intimp.2013.04.033","type":"journal-article","created":{"date-parts":[[2013,5,10]],"date-time":"2013-05-10T09:30:13Z","timestamp":1368178213000},"page":"488-491","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Effect of cyclosporine on lymphocytic variant hypereosinophilic syndrome"],"prefix":"10.1016","volume":"16","author":[{"given":"Rie","family":"Tabata","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiharu","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Katashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoji","family":"Yasumizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2013.04.033_bb0005","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1182\/blood.V83.10.2759.2759","article-title":"The idiopathic hypereosinophilic syndrome","volume":"83","author":"Weller","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2013.04.033_bb0010","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1182\/asheducation-2005.1.209","article-title":"Recent advances in the diagnosis and treatment of hypereosinophilic syndromes","author":"Klion","year":"2005","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.intimp.2013.04.033_bb0015","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MOH.0b013e32831c841f","article-title":"Advances in diagnosis and treatment of eosinophilia","volume":"16","author":"Sheikh","year":"2009","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.intimp.2013.04.033_bb0020","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A novel tyrosine kinase created by the fusion of the PDGFRA and FIP1L1 genes is a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.intimp.2013.04.033_bb0025","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1182\/blood-2003-01-0006","article-title":"Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis and imatinib-responsiveness","volume":"101","author":"Klion","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2013.04.033_bb0030","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJM199910073411503","article-title":"Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia","volume":"341","author":"Simon","year":"1999","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.intimp.2013.04.033_bb0035","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.iac.2007.07.002","article-title":"Lymphocytic variant hypereosinophilic syndromes","volume":"27","author":"Roufosse","year":"2007","journal-title":"Immunol Allergy Clin North Am"},{"issue":"7","key":"10.1016\/j.intimp.2013.04.033_bb0040","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1002\/eji.200635972","article-title":"IL-4 induces expression of TARC\/CCL17 via two STAT6 binding sites","volume":"36","author":"Wirnsberger","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.intimp.2013.04.033_bb0045","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1067\/mai.2002.127003","article-title":"High serum thymus and activation-regulated chemokine levels in the lymphocytic variant of the hypereosinophilic syndrome","volume":"110","author":"de Lavareille","year":"2002","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.intimp.2013.04.033_bb0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1034\/j.1398-9995.2002.5720256.x","article-title":"Increased levels of a TH2-type CC chemokine thymus and activation-regulated chemokine (TARC) in serum and induced sputum of asthmatics","volume":"57","author":"Sekiya","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.intimp.2013.04.033_bb0055","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.jaci.2006.02.042","article-title":"Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report","volume":"117","author":"Klion","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2013.04.033_bb0060","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.iac.2007.07.003","article-title":"Novel approaches to therapy of hypereosinophilic syndromes","volume":"27","author":"Simon","year":"2007","journal-title":"Immunol Allergy Clin North Am"},{"issue":"3","key":"10.1016\/j.intimp.2013.04.033_bb0065","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1067\/mai.2001.113237","article-title":"Thymus and activation regulated chemokine in atopic dermatitis: Serum thymus and activation-regulated chemokine level is closely related with disease activity","volume":"107","author":"Kakinuma","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.intimp.2013.04.033_bb0070","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/j.jaci.2009.09.022","article-title":"Hypereosinophilic syndromes: a multicenter, retrospective analysis of clinical characteristics and response to therapy","volume":"124","author":"Ogbogu","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.intimp.2013.04.033_bb0075","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1182\/blood.V79.12.3101.bloodjournal79123101","article-title":"Interleukin-5, eosinophils, and disease","volume":"79","author":"Sanderson","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.intimp.2013.04.033_bb0130","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.4049\/jimmunol.159.3.1459","article-title":"Differential effects of the T helper cell type 2-derived cytokines IL-4 and IL-5 on ligand binding to IgG and IgA receptors expressed by human eosinophils","volume":"159","author":"Bracke","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.04.033_bb0085","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1165\/ajrcmb.20.3.3326","article-title":"Synergistic effects of interleukin-4 or interleukin-13 and tumor necrosis factor-alpha on eosinophil activation in vitro","volume":"20","author":"Luttmann","year":"1999","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"4","key":"10.1016\/j.intimp.2013.04.033_bb0090","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1002\/eji.1830230429","article-title":"Human peripheral blood eosinophils produce and release interleukin-8 on stimulation with calcium ionophore","volume":"23","author":"Braun","year":"1993","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.intimp.2013.04.033_bb0095","doi-asserted-by":"crossref","first-page":"588","DOI":"10.4049\/jimmunol.166.1.588","article-title":"IL-8 induces a transient arrest of rolling eosinophils on human endothelial cells","volume":"166","author":"Ulfman","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.intimp.2013.04.033_bb0100","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1165\/rcmb.2005-0303OC","article-title":"Eosinophil trans-basement membrane migration induced by interleukin-8 and neutrophils","volume":"34","author":"Kikuchi","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9","key":"10.1016\/j.intimp.2013.04.033_bb0105","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1398-9995.2012.02873.x","article-title":"Serum biomarkers are similar in Churg\u2013Strauss syndrome and hypereosinophilic syndrome","volume":"67","author":"Khoury","year":"2012","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.intimp.2013.04.033_bb0110","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jaci.2010.06.049","article-title":"Mepolizumab as a corticosteroid-sparing agent in lymphocytic variant hypereosinophilic syndrome","volume":"126","author":"Roufosse","year":"2010","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.intimp.2013.04.033_bb0115","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1111\/j.1600-6143.2005.01071.x","article-title":"Calcineurin inhibitor effects on growth and phenotype of human airway epithelial cells in vitro","volume":"5","author":"Neuringer","year":"2005","journal-title":"Am J Transplant"},{"issue":"12","key":"10.1016\/j.intimp.2013.04.033_bb0120","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1177\/0022034509350566","article-title":"Cyclosporin A and phenytoin modulate inflammatory responses","volume":"88","author":"Suzuki","year":"2009","journal-title":"J Dent Res"},{"issue":"6","key":"10.1016\/j.intimp.2013.04.033_bb0125","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/ICO.0b013e3182012a61","article-title":"Effect of tacrolimus on chemokine production by corneal myofibroblasts via toll-like receptors, compared with cyclosporine and dexamethasone","volume":"30","author":"Ebihara","year":"2011","journal-title":"Cornea"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913001793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576913001793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T16:56:58Z","timestamp":1688230618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576913001793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1567576913001793"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2013.04.033","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of cyclosporine on lymphocytic variant hypereosinophilic syndrome","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2013.04.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}